GlassScriptPhysician profile
Jean C. Desir
NPI 1447005442
$2,041.87
in general payments reported to CMS, 2019-2025
10 companies · $863 in 2025
The $863 reported for 2025 was more than what 77% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $224 · 2023: $220 · 2024: $735 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $601.47 | 2022-2024 | Reblozyl, Opdivo |
| Janssen Biotech, INC. | $261.18 | 2025 | Rybrevant, Carvykti |
| Amgen INC. | $219.28 | 2025 | Blincyto |
| Adc Therapeutics America, INC. | $125.48 | 2024 | |
| Genmab U.S., INC. | $124.99 | 2025 | Epkinly |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2023 | Imfinzi |
| Emd Serono, INC. | $110.31 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $109.71 | 2024 | Libtayo |
| Dendreon Pharmaceuticals LLC | $103.46 | 2025 | Provenge |
| Insightec,INC | $44.24 | 2025 | Exablate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Desir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.